Anti-Diabetic - taste masking technology, Coating technology, comparatively evaluation, Solubilization technology, Modifying release technology, Micromeritics enhancement technology, Photo-stability & Photo-degradation technology, Comparison of Natural and Chemical excipients in drug release
Orodispersible, Fast dissolving, Fast disintegration technology Gastroretantive technology, Statistical design, SAS, Control chart, Content uniformity, Algorithm model, Ion exchange resin, Taste evaluation, Sustain release, Bilayer technology
Physical characterization – DSC, XRD, FTIR (Phytochemical screening) Method development- Isolation, active confirmation by UV, HPLC Antifungal activity, botanical extraction and active identification.
Phytochemical characterization- Diabetic Formulation, Algorithm, Case study of Diabetes, AI Model of synergistic Phyto-Botanical– Diabetes Animal study- Diabetes.
Granulation technology without excipients in phytoconstituents, Algorithm of Synergy effect of Phytoconstituent and Phytochemical Developed Anti-Cholesterol and Anti-Obesity formulation, Case study of Diabetes, Anti-Cholesterol, Anti-Obesity, Analysis and Stability study of Diabetes, Anti-Cholesterol & Anti-Obesity formulation, Curcumin solubility and Bioavailability and Leukemia case study.
Statistical Optimization of Arthritis, Piles, Kidney stone, Allergic cough cold, Digestive care formulation- Case study, Control chart statistical desig, Comparative analysis of Phyto ingredients from different sources
Phytochemical concentration and its solubility Comparative analysis of Solubility from Chemical with natural additives, Heavy metal and Microbial study on different Phytoconstituents with Herbal raw materials
Self-micro-emulsion (SMEDDS) technology in Herbal, Lyophilization (Freeze drying) of herbal extracts, Vacuum drying and dehydrators of herbal isolated compound, Photostability effect on different Phytochemicals and API, Force degradation of Different Phytochemicals and API, Characterization of Synergy Phytochemical/Phytoconstituents by HPLC, HPTLC, GC, FTIR, XRD, DSC, Natural superdisintegrant, Natural preservative, Natural modifying release dosage ingredients comparison with Std Excipients, Marketed Formulation with more 6 Products. (Cough cold, Liver detox, Kidney stone, Male fertility, Female fertility, Piles)
Case study & Optimization of Algorithm, Developed India first Excipientless tablet dosage form (Tablet) proven as per IVIVC model, Developed Aqueous tablet coating technology, Upgrade Algorithm as per Clinical studies
Statistical Optimization of Arthritis, Piles, Kidney stone, Allergic cough cold, Digestive care formulation- Case study, Control chart statistical desig, Comparative analysis of Phyto ingredients from different sources
Patent Drafting started, started working on Cosmetics and Consult 3-4 companies, Add more 7 Products like B12, Multivitamins, Some topical. Started survey on regulatory of Botanical Nutraceutical, Dietary supplement
Started to explore research in different country through speaker, Registered Gplife as Gplife Healthcare Pvt Ltd, started working on IVIVC AI model, Developed Synergy effect Phyto Model, more than 350+ Phyto ingredients analytically tested, Ready AI model of Synergistic effect for new disease, Animal toxicity study of Diabetic formulation, Diabetes clinical trial (Type-1&2), Diabetes case study, Total 18 Products Case studies
Covid Animal study & Covid Clinical trial, Total 20 Patent drafted, Covid (Ayurvedic medicine) Developed, Covid Data published, Covid (Ayurvedic medicine) Clinical trial (Phase-3) Cleared, Clinical trial and Case study Publication
Clinical trial in 8 chronic diseases cleared, Total 12 Patent Submitted, 08 ready for submission, New 30 Patent Drafting started on Technology, Algorithm ready for Software based AI Model, Beta cell regeneration breakthrough, Cartilage regeneration, Synovial fluid regeneration breakthrough, Time in range Paper Publication, Diabetes (Type-1) Insulin dependent patients case study publication, Total 50 Products put in the Market, Working on 150+ New product development, Diabetes Stem cell regeneration
In process- Phyto Plant survey, Analytical lab survey, AI team, IPR team, CRO team, Research & Development team, Regulatory affairs, Scientific writer, BA/BE study, Biotechnology (Cell regeneration), Toxicokinetic and Pharmacokinetic.
Over the past 19 years, we have dedicated ourselves to finding solutions for some of the world’s biggest unsolved chronic diseases, including Type-2 Diabetes, Type-1 Diabetes, Arthritis, Chronic Liver Diseases, Chronic Kidney Diseases, Chronic Cardiovascular Diseases, Obesity, Respiratory Diseases, Gut disease, Insomnia, Vision problem, Hair loss, Vitamin deficiency and many more
Our team is committed to taking on the challenge of solving these diseases and improving the quality of life for millions of people around the world.
At Gplife nutrition, we are able to meet all these minimum requirements by using a new scientific mechanism to causally solve diseases with novel pharmacological action.
Chief Scientific Officer (CSO) - Research and Innovation
Chief Technical Officer (CTO)
Chief Executive officer (CEO)
Head – Head, Clinical
Research (CRO)
Chief financial officer (CFO)
GERMANY
UAE
SINGAPORE
INDIA
USA
USA
CANADA
INDIA
QATAR
MALAYSIA
INDIA
USA
GERMANY
INDIA
CANADA
DUBAI
INDIA
INDIA
INDIA
CANADA
PARIS
INDIA
RUSSIA
USA
First, Do No Harm
Replace All Unscientific Drugs with Botanical Active Causality target dosage form
Become Scientifically Proven Adjuvant Treatment for every Phytochemistry based dosage we invent
Solve Chronic Diseases by cell regeneration active causality target and Make Healthcare Noble Again
Innovation - We are expertise in synergistic phytochemical active causality target molecules derived from botanical ingredients to solve chronic disease.
Purity - Our Products are derived from pure botanical isolated standardized form, Compliance with Quality, Toxicity and Stability guideline.
Excellence - Our Artificial intelligence model, process patentability and measurable outcomes by clinical research are key USP of our research whatweinventtomakehealthcare nobleagain.